Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vasodilator
inotrope phosphodiesterase 3 inhibitor |
| gptkbp:approvedBy |
1980s
|
| gptkbp:ATCCode |
C01CE02
|
| gptkbp:CASNumber |
78415-72-2
|
| gptkbp:discoveredBy |
gptkb:Winthrop_Laboratories
|
| gptkbp:effect |
increases cardiac contractility
decreases afterload |
| gptkbp:eliminationHalfLife |
2.3 hours
|
| gptkbp:excretion |
renal
|
| gptkbp:hasMolecularFormula |
C12H9N3O
|
| https://www.w3.org/2000/01/rdf-schema#label |
milrinone
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
increases cAMP by inhibiting phosphodiesterase 3
|
| gptkbp:metabolism |
minimal hepatic metabolism
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
gptkb:arrhythmia
hypotension thrombocytopenia |
| gptkbp:synonym |
Primacor
|
| gptkbp:usedFor |
heart failure
cardiogenic shock |
| gptkbp:bfsParent |
gptkb:Cyclic_Phosphodiesterase
|
| gptkbp:bfsLayer |
6
|